Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1000207-51-1

Post Buying Request

1000207-51-1 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • (2-Chloro(5,6,7-trihydrocyclopenta[2,1-e]pyrimidin-4-yl))-4-piperidylamine hydrochloride

    Cas No: 1000207-51-1

  • No Data

  • No Data

  • No Data

  • SAGECHEM LIMITED
  • Contact Supplier
  • 2-Chloro-N-(piperidin-4-yl)-6,7-dihydro-5H-cyclopenta-[d]pyrimidin-4-amine hydrochloride

    Cas No: 1000207-51-1

  • No Data

  • No Data

  • No Data

  • NovaChemistry
  • Contact Supplier

1000207-51-1 Usage

General Description

(2-Chloro(5,6,7-trihydrocyclopenta[2,1-e]pyriMidin-4-yl))-4-piperidylaMine hydrochloride is a chemical compound that is used in pharmaceutical research and drug development. It is a derivative of the pyrimidine ring system and contains a piperidine group. (2-Chloro(5,6,7-trihydrocyclopenta[2,1-e]pyriMidin-4-yl))-4-piperidylaMine hydrochloride has potential therapeutic applications due to its ability to interact with biological targets in the body. The hydrochloride salt form of the compound makes it more stable and easier to handle in laboratory and manufacturing processes. The chemical structure and properties of this compound make it a valuable tool for studying biological processes and developing new drugs for a variety of medical conditions.

Check Digit Verification of cas no

The CAS Registry Mumber 1000207-51-1 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,0,0,2,0 and 7 respectively; the second part has 2 digits, 5 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 1000207-51:
(9*1)+(8*0)+(7*0)+(6*0)+(5*2)+(4*0)+(3*7)+(2*5)+(1*1)=51
51 % 10 = 1
So 1000207-51-1 is a valid CAS Registry Number.

1000207-51-1Downstream Products

1000207-51-1Relevant articles and documents

PYRIMIDINE AND QUINAZOLINE DERIVATIVES

-

Page/Page column 71, (2008/06/13)

This invention is concerned with compounds of the formula ( l ) wherein A, R1 to R5 and G are as defined in the description and claims, and pharmaceutically acceptable salts thereof. The invention further relates to pharmaceutical compositions containing such compounds, to a process for their preparation and to their use for the treatment and/or prevention of diseases which are associated with the modulation of SST receptors subtype 5.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1000207-51-1